SHANGHAI – Biotech entrepreneurs in China pursuing innovative drugs often straddle two, if not three, worlds. They have a deep knowledge of the scientific, regulatory and commercial landscape of China as well as the U.S. And, crucially, they have the ability to envision what the China market of the future will look like.